Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private

BSE2092.10-98.55 (-4.5 %)

PREV CLOSE ( ) 2190.65

OPEN PRICE ( ) 2279.90

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 107017

TODAY'S LOW / HIGH ( )2063.75 2294.90

52 WK LOW / HIGH ( )1240.75 2488.65

NSE2092.55-98.2 (-4.48 %)

PREV CLOSE( ) 2190.75

OPEN PRICE ( ) 2281.00

BID PRICE (QTY) 2092.55 (709)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3462277

TODAY'S LOW / HIGH( ) 2060.00 2299.00

52 WK LOW / HIGH ( )1242 2490

Select year

(Rs.in Million)

Particulars

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Mar 2019

Profit Before Tax

16712.39

19746.01

16916.11

14377.35

8646.63

Adjustment

2984.30

308.07

-56.59

1054.57

872.90

Changes In working Capital

1667.29

-5861.21

-946.33

-1400.77

-97.39

Cash Flow after changes in Working Capital

21363.98

14192.87

15913.19

14031.16

9422.14

Cash Flow from Operating Activities

18133.02

9197.79

11372.44

10722.04

6003.72

Cash Flow from Investing Activities

-10541.29

-13691.44

-12222.11

-4391.54

-4443.45

Cash Flow from Financing Activities

-7397.28

6046.21

-78.11

-5269.69

-1751.49

Net Cash Inflow / Outflow

194.45

1552.55

-927.78

1060.82

-191.21

Opening Cash & Cash Equivalents

2830.60

1273.27

2197.31

1163.90

1355.36

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

23.15

4.78

3.75

36.04

-0.24

Closing Cash & Cash Equivalent

3048.21

2830.60

1273.28

2260.75

1163.90